Sechenov School
Home › Pharmacology › Naphazoline: Pharmacology, Mechanism and Clinical Use

Naphazoline

Naphtysinum

For medical students2 min readUpdated 2026-10-10

Naphazoline is a medication that regulates the peripheral nervous system. As a local $\alpha_2$-adrenergic agonist, it produces marked vasoconstriction and is used primarily in ENT practice to relieve mucosal congestion.

Drug Class$\alpha_2$-adrenergic agonist (imidazoline derivative)
TargetPeripheral $\alpha_2$-adrenergic receptors
Formulations0.05% and 0.1% solutions in 10 mL vials
Route of AdministrationIntranasal (into the nasal passages)

Chemical Structure and Classification

Chemically, naphazoline (Naphtysinum) belongs to the imidazoline derivatives. This structural group also includes oxymetazoline, xylometazoline, and tetryzoline.

Pharmacologically, the drug is classified among agents that regulate the peripheral nervous system. By mechanism of action, it is a predominantly locally acting $\alpha_2$-adrenergic agonist.

Pharmacodynamics and Mechanism of Action

The primary target of the drug is peripheral $\alpha_2$-adrenergic receptors.

Upon stimulation of these receptors, naphazoline produces a pronounced vasoconstrictive effect (vasoconstriction).

Pharmacological comparison: It is important to note that the vasoconstrictive effect of imidazoline derivatives (including naphazoline) is longer-lasting than that of classic $\alpha_1$-adrenergic agonists such as phenylephrine.

Clinical Application in ENT Practice

The drug is available in various topical formulations: drops, sprays, and emulsions. Its main clinical indication is intranasal administration for rhinitis.

The mechanism of the therapeutic effect follows a sequential cascade:

  1. Local vasoconstriction of the nasal mucosa blood vessels.
  2. Reduction of local tissue edema.
  3. Improvement of mucus drainage from the paranasal sinuses.
  4. Decreased blood flow to venous sinusoids.

Clinical result: Rapid and effective relief of nasal congestion and restored breathing.

Systemic (Central) Effects of Alpha-2 Adrenergic Agonists

Although naphazoline is used as a topical agent, students must understand the systemic effects of the entire $\alpha_2$-adrenergic agonist class. Centrally acting agents in this group include clonidine, guanfacine, methyldopa, and tizanidine.

Upon systemic absorption (entering the systemic circulation) and stimulation of $\alpha_2$-adrenergic receptors in the CNS, the following effects develop:

Formulations and Prescription Guidelines

The medication is prescribed as solutions of varying concentrations.

Prescription example:

`Rp.: Sol. Naphtysini 0.1% - 10 ml` `D.S. Instill 2-3 drops into each nasal passage 3-4 times a day.`

Mnemonic

Drugs ending in "-ZOLINE" (Naphazoline, Xylometazoline) are imidazOLINE derivatives that stimulate $\alpha_2$ receptors to cause vasoconstriction.

Frequently asked questions

To which chemical group does naphazoline belong?

Chemically, the drug is an imidazoline derivative.

How does naphazoline's action differ from phenylephrine?

Naphazoline stimulates $\alpha_2$-adrenergic receptors and produces a longer-lasting vasoconstrictive effect, whereas phenylephrine is an $\alpha_1$-adrenergic agonist.

How exactly does the drug relieve congestion in rhinitis?

It constricts the blood vessels of the nasal mucosa, leading to decreased edema, reduced blood flow to venous sinusoids, and improved drainage from the paranasal sinuses.

What effects occur upon stimulation of CNS $\alpha_2$-adrenergic receptors?

Central effects develop: hypotension (decreased blood pressure), sedation, analgesia, and hypothermia.

Go deeper

More topics in Pharmacology

Biologic Agents in Rheumatoid ArthritisGanglionic BlockersPulmonary Surfactants: Pharmacology and Clinical UseAntipseudomonal PenicillinsBone Marrow Preparations: Myelopid PharmacologyHerbal AntisepticsParacetamolAnticoagulantsAtenololIrbesartanNeostigmineRibavirinPharmacology →